Landgren, C. O., Ye, J. C., Hillengass, J., Sborov, D. W., Hoffman, J. E., Diamond, B., Coffey, D. G., Kaddoura, M., Pandey, A., Koubek, K., Mompoint, S., Gutierrez, S., Diaz, C., Armogan, M., Baz, R. C., Orlowski, R., Jandl, T. A., Korde, N., Shain, K. H., Kazandjian, D. G. (2025). Randomized, multi-center study of carfilzomib, lenalidomide, and dexamethasone (KRd) with or without daratumumab (D) in patients with newly diagnosed multiple myeloma (NDMM): The ADVANCE clinical trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7503